PDF(3391 KB)
舌黏膜癌变基因组甲基化分析
刘华, 岳万远, 邵帅, 孙家平, 杨莹, 代晓明
PDF(3391 KB)
PDF(3391 KB)
舌黏膜癌变基因组甲基化分析
), 岳万远1, 邵帅1, 孙家平1, 杨莹2, 代晓明3Global analysis of DNA methylation changes during experimented lingual carcinogenesis
), Yue Wanyuan1, Shao Shuai1, Sun Jiaping1, Yang Ying2, Dai Xiaoming3目的 研究舌黏膜癌变过程中基因组甲基化特征，探讨舌癌中DNA甲基化的规律。 方法 用50 mg/L的4-硝基喹啉-1-氧化物（4NQO）饮水诱导C57BL/6J小鼠舌黏膜癌变，分别取第0、12、28周的舌黏膜（分别代表正常、癌前病变和癌变）进行基因芯片检测和甲基化DNA免疫沉淀测序（MeDIP-Seq），在人舌黏膜组织和人舌癌细胞系中，用实时定量逆转录聚合酶链反应（qRT-PCR）和飞行质谱检测验证转化生长因子贝塔信号蛋白1（SMAD1）的表达和启动子的甲基化。 结果 28周较12周和0周舌黏膜的胞嘧啶鸟嘌呤岛（CGI）甲基化水平均升高，12周时启动子甲基化水平高于0周。在0、12和28周期间，208个差异表达基因与启动子中的差异甲基化呈负相关。与正常黏膜相比，细胞系中SMAD1的mRNA上调，同时启动子甲基化水平降低。 结论 舌黏膜癌变中伴随DNA甲基化修饰异常，舌癌中SMAD1高表达伴启动子低甲基化。
Objective This study aims to assess the role of DNA methylation changes in tongue cancer through a comprehensive analysis of global DNA methylation alterations during experimental lingual carcinogenesis. Methods C57BL/6J mice were subjected to 16-week oral administration of 4-nitroquinoline-1-oxide (4NQO, 50 mg/L). Lingual mucosa samples, being representative of normal tissue (week 0) and early (week 12) and advanced (week 28) tumorigenesis, were harvested for microarray and methylated DNA immunoprecipitation sequencing (MeDIP-Seq). The mRNA and promoter methylation of transforming growth factor-beta-signaling protein 1 (SMAD1) were evaluated with real-time quantitative reverse transcription polymerase chain reaction and Massarray in human lingual mucosa and tongue cancer cell lines. Results The cytosine guanine island (CGI) methylation level observed at 28 weeks surpassed that of both 12 weeks and 0 weeks. The promoter methylation level at 12 weeks exceeded that at 0 weeks. Notably, 208 differentially expressed genes were negatively correlated to differential methylation in promoters among 0, 12, and 28 weeks. The mRNA of SMAD1 was upregulated, concurrent with a decrease in promoter methylation levels in cell lines compared to normal mucosa. Conclusion DNA methylation changed during lingual carcinogenesis. Overexpression of SMAD1 was correlated to promoter hypomethylation in tongue cancer cell lines.
舌癌 / 发病机制 / 甲基化 / 动物模型 / 甲基化DNA免疫沉淀测序 / 差异表达基因
tongue cancer / pathogenesis / methylation / animal model / methylated DNA immunoprecipitation sequencing / differentially expressed genes
R739.86
| 1 | Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K,et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019[J]. JAMA Oncol, 2022, 8(3): 420-444. |
| 2 | Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. |
| 3 | 代晓明, 刘华, 左志斌, 等. 4-硝基喹啉-1-氧化物诱导C57BL/6小鼠舌黏膜癌变的研究[J]. 华西口腔医学杂志, 2015, 33(4): 357-360. |
| 3 | Dai XM, Liu H, Zuo ZB, et al. Study on lingual mucosa carcinogenesis of C57BL/6 mice induced by 4-nitroquinoline 1-oxide[J]. West China J Stomatol, 2015, 33(4): 357-360. |
| 4 | Laird PW, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics[J]. Annu Rev Genet, 1996, 30: 441-464. |
| 5 | Towle R, Truong D, Hogg K, et al. Global analysis of DNA methylation changes during progression of oral cancer[J]. Oral Oncol, 2013, 49(11): 1033-1042. |
| 6 | Lai ZL, Tsou YA, Fan SR, et al. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma[J]. Biomed Res Int, 2014, 2014: 378358. |
| 7 | Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1[J]. Nature, 1997, 389(6651): 618-622. |
| 8 | Liu H, Li J, Yang Y, et al. Alterations of 63 hub genes during lingual carcinogenesis in C57BL/6J mice[J]. Sci Rep, 2018, 8(1): 12626. |
| 9 | Wang Q, Xiong F, Wu G, et al. Gene body methylation in cancer: molecular mechanisms and clinical applications[J]. Clin Epigenetics, 2022, 14(1): 154. |
| 10 | Foy JP, Pickering CR, Papadimitrakopoulou VA, et al. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development[J]. Cancer Prev Res (Phila), 2015, 8(11): 1027-1035. |
| 11 | Zeng Y, Chen T. DNA methylation reprogramming during mammalian development[J]. Genes (Basel), 2019, 10(4): 257. |
| 12 | Martino D, Loke YJ, Gordon L, et al. Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic chan-ge in early life and pair-specific effects of discordance[J]. Genome Biol, 2013, 14(5): R42. |
| 13 | Teschendorff AE, West J, Beck S. Age-associated epigenetic drift: implications, and a case of epigenetic thrift[J]. Hum Mol Genet, 2013, 22(R1): R7-R15. |
| 14 | Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer[J]. Proc Natl Acad Sci U S A, 1999, 96(15): 8681-8686. |
| 15 | Liang G, Weisenberger DJ. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers[J]. Epigenetics, 2017, 12(6): 416-432. |
| 16 | Rechache NS, Wang Y, Stevenson HS, et al. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors[J]. J Clin Endocrinol Metab, 2012, 97(6): E1004-E1013. |
| 17 | Chang MS, Uozaki H, Chong JM, et al. CpG island me-thylation status in gastric carcinoma with and without infection of Epstein-Barr virus[J]. Clin Cancer Res, 2006, 12(10): 2995-3002. |
| 18 | Geli J, Kiss N, Karimi M, et al. Global and regional Cp-G methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior[J]. Clin Cancer Res, 2008, 14(9): 2551-2559. |
| 19 | Fazal Z, Singh R, Fang F, et al. Hypermethylation and global remodelling of DNA methylation is associated wi-th acquired cisplatin resistance in testicular germ cell tumours[J]. Epigenetics, 2021, 16(10): 1071-1084. |
| 20 | Yang X, Han H, De Carvalho DD, et al. Gene body me-thylation can alter gene expression and is a therapeutic target in cancer[J]. Cancer Cell, 2014, 26(4): 577-590. |
| 21 | Huang KK, Ramnarayanan K, Zhu F, et al. Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer[J]. Cancer Cell, 2018, 33(1): 137-150.e5. |
| 22 | Lai AY, Fatemi M, Dhasarathy A, et al. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas[J]. J Exp Med, 2010, 207(9): 1939-1950. |
| 23 | McGuire MH, Dasari SK, Yao H, et al. Gene body methylation of the lymphocyte-specific gene card11 results in its overexpression and regulates cancer mtor signaling[J]. Mol Cancer Res, 2021, 19(11): 1917-1928. |
| 24 | Inchanalkar M, Srivatsa S, Ambatipudi S, et al. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers[J]. Clin Epigenetics, 2023, 15(1): 93. |
| 25 | Basu B, Chakraborty J, Chandra A, et al. Genome-wide DNA methylation profile identified a unique set of diffe-rentially methylated immune genes in oral squamous cell carcinoma patients in India[J]. Clin Epigenetics, 2017, 9: 13. |
/
| 〈 |
|
〉 |
AI Summary
